Klotho Neurosciences, Inc.
Develops gene and cell therapies for age-related neurodegenerative disorders.
KLTO | US
Overview
Corporate Details
- ISIN(s):
- US7580831094 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 13576 WALNUT STREET, SUITE A, 68144 OMAHA
- Website:
- https://klothoneuro.com/
- Sector:
- Manufacturing
Description
Klotho Neurosciences, Inc. is a biopharmaceutical company focused on the development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders. The company develops treatments for conditions with high unmet medical needs, including amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's disease. Its core approach involves pioneering gene and cell therapies that utilize DNA and RNA as therapeutics. A key area of its research is centered on genomic therapies targeting the alpha-Klotho gene, a known regulator of aging. The company's portfolio consists of proprietary cell and gene therapy programs designed to offer transformative outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Klotho Neurosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Klotho Neurosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Klotho Neurosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
